Johnson & Johnson
强生公司
elsewhere's corpus does not cover Johnson & Johnson as a subject — the retrieved material only mentions it in passing as a partner in XtalPi's research collaborations and as a former employer of Kan Chen, not as a profiled entity in its own right. No document chunk is actually about Johnson & Johnson.
AI-generated — may contain errors, please verify.
Coverage
What's the Best Form for an Investment Research Agent? AlphaEngine Offers a New Answer
How far can OpenClaw go in the investment research space?
How Does Dalton Venture Precisely Capture Investment Growth Opportunities by Focusing on Cardiovascular Disease Diagnosis, Treatment, and Management? | Dalton Insights
For decades, cardiovascular disease has been considered the "leading killer" threatening global human health and longevity, with mortality rates reaching 5% among patients over 65. As population aging accelerates and lifestyles shift, the prevalence of chronic heart conditions is rising markedly — spurring waves of innovation across cardiovascular device segments to address persistent treatment pain points and improve diagnostic and therapeutic efficiency and safety.
Interview with RayzeBio: Two Funding Rounds in Six Months, How the Surging "Radiopharma" Sector Is Transforming Cancer Treatment | Gaorong Ventures
Accelerating on the "fast track" of TRT therapy.
November, a World of Infinite Possibilities | 5Y News Monthly
The big news from last month.
From Nobel Discovery to Clinical Application: Mirxes Is Transforming Cancer Early Screening with miRNA Technology | Gaorong Ventures
Focused on miRNA technology development, pioneering early cancer screening worldwide.
Qiming Venture Partners' Kan Chen: There's an Optimal Path for Chinese Innovative Drugs Going Global
Move beyond single concepts and invest in "global biotech."
"AI + Vertical Industry Applications" Salon Recap: What's Changing in Marketing, Law, and Healthcare?
Since ChatGPT's official launch, the generative AI-driven entrepreneurship wave has continued to spread globally — and after 300 days, the赛道 remains as hot as ever. The long-term value proposition that **generative AI will transform productivity** has become an industry consensus. Yet the road ahead is long. The harder questions behind this revolution are how to **translate technology into real-world deployment, accelerate the development of innovative applications in vertical scenarios, and achieve commercialization**.
Beyond What Meets the Eye | 5Y News Monthly
The big news from last month.
Code Brain | Navigating Supply Chains Amid "Volatility"
"Together for a Shared Future"
Source Code Capital portfolio company "moody" announced the completion of a Series C funding round exceeding 1 billion RMB, with existing shareholder Source Code Capital continuing to increase its stake.
Strengthen research teams and R&D centers, and accelerate international expansion.
5Y News | moody Announces Completion of Series C Funding Round Exceeding RMB 1 Billion
How Did They Become an Industry Champion in Just Two Years?
Source Code Capital portfolio company "MOODY" announced the completion of 380 million yuan in Series B and B+ funding, with existing shareholder Source Code Capital continuing to increase its stake.
Within three months of its founding, the company launched on Tmall and broke RMB 200 million in transaction volume in its first year.
Your Eyes Hold the Galaxy: How Colored Contact Lenses Became a Hit in One Chart | FreeS Research
China's Young People Embrace the Colored-Contact-Lens Era
In Our Sixth Year, FreeS Fund Is Hiring Investors | Let's Do What's Right, Not What's Easy
Betting on the power of innovation, staying research-driven.
New Retail Entrepreneurship: Move Fast, Fight Hard, and Cultivate with Care | FreeS Talk
Fresh observations on office unmanned shelves, home furnishings, matcha, and personal care.
